Features of Providing Highly Specialized Medical Care to Pregnant Women with Covid-19 in Obstetric Practice

This article examines the intricate clinical strategies for delivering specialised medical care to pregnant mothers diagnosed with COVID-19. Managing these individuals has considerable problems, since the disease trajectory can quickly transition from mild to life-threatening, necessitating prompt and tailored medicinal interventions. A primary problem is establishing suitable obstetric strategies based on gestational age, the severity of the maternal disease, and foetal health. During early pregnancy, especially prior to 12 weeks, termination may be contemplated due to the teratogenic effects of medication and the potential dangers of foetal abnormalities. Nevertheless, if the pregnancy persists, diagnostic interventions such as chorionic villus sampling or amniocentesis may be required to assess foetal well-being.

In moderate to severe COVID-19 cases, delivery may be required to avert maternal decline, particularly in the presence of comorbidities like as respiratory failure, pulmonary oedema, or septic shock. Caesarean section is the preferable procedure in critical situations, with anaesthesia customised to the mother condition. Regional anaesthesia is advised when possible, but intravenous anaesthesia is designated for severe multi-organ failure. Neonatal treatment is of paramount importance. Newborns are deemed at risk if the mother has confirmed or suspected COVID-19. Immediate isolation, diagnostic testing for SARS-CoV-2, and stringent infection control measures are instituted at birth. Delayed cord clamping and mother-infant interaction are prohibited to mitigate transmission risk. The prognosis for both the mother and newborn depends on the severity of the disease, the timing of the infection during pregnancy, and the existence of pre-existing health issues. Multidisciplinary collaboration and evidence-based methods are crucial for enhancing outcomes.